Medical device site joint infections represent one of the most serious challenges that can occur when artificial joints or orthopedic hardware are implanted into the body. Though relatively uncommon—affecting roughly one to two percent of patients who receive joint replacements—these infections can profoundly impact a person’s life, requiring prolonged treatment, multiple surgeries, and sometimes even the removal of the implant itself.

Understanding the Challenge: When Infection Threatens Joint Implants

When someone undergoes surgery to replace a damaged joint with an artificial one, the goal is always to relieve pain and restore movement. The vast majority of these procedures succeed beautifully. However, in a small percentage of cases, bacteria find their way to the implanted device and cause an infection that is particularly difficult to treat.^[1] Unlike infections in natural joints, these prosthetic joint infections—also called periprosthetic joint infections or PJI—are uniquely stubborn because the artificial materials provide a surface where bacteria can cling and form protective communities called biofilms.^[1]

The presence of metal, plastic, or ceramic implants in the body fundamentally changes how infections behave. Our immune system relies on blood flow to detect and fight invading bacteria, but since artificial joints receive no blood supply, the body struggles to identify and eliminate bacteria that attach to these surfaces.^[2] This means that a much smaller number of bacteria can cause an infection around an implant than would be needed to infect a natural joint.^[1]

The consequences of these infections extend far beyond physical discomfort. Patients face emotional distress, prolonged hospital stays, weeks or months of antibiotic therapy, and often multiple surgical procedures.^[4] The financial burden is significant as well—revision surgery costs can reach approximately $50,000 per case.^[4] Most importantly, these infections increase both patient suffering and, in some cases, mortality risk.^[1]

Treating medical device site joint infections focuses on several interconnected goals: eradicating the infection itself, preserving as much joint function as possible, relieving pain, and preventing the infection from returning or spreading. The approach to treatment depends heavily on how soon the infection is detected after surgery, what type of bacteria is causing it, the overall health of the patient, and whether the implant remains stable or has loosened.^[14] There is no single solution that works for everyone—instead, physicians tailor treatment plans to each individual’s unique circumstances.

How These Infections Occur

Understanding how bacteria reach implanted devices helps explain why treatment can be so complex. Most commonly, bacteria are introduced during the surgery itself, even when strict sterile protocols are followed. These microorganisms typically come from the patient’s own skin.^[1] Despite rigorous cleaning and prophylactic antibiotics, a tiny number of bacteria can sometimes survive and attach to the new implant.

However, infections don’t always start during the operation. They can also develop weeks, months, or even years later through a process called hematogenous seeding—meaning bacteria travel through the bloodstream from another infected site in the body and settle on the implant.^[1] For instance, bacteria from a urinary tract infection, a dental procedure, or even a skin wound can enter the bloodstream and find their way to a previously healthy joint replacement.^[2]

The bacteria most often responsible are species that normally live on human skin, particularly various types of staphylococci. Staphylococcus aureus is a particularly aggressive culprit, while less virulent organisms like coagulase-negative staphylococci can cause slower-developing infections that might not become obvious for many months.^[3] Occasionally, other bacteria, fungi, or even parasites can be involved.^[11]

The timing of infection provides important clues about its origin and helps guide treatment decisions. Medical professionals classify these infections into three categories based on when symptoms appear. Early onset infections occur within the first three months after surgery and are usually caused by more aggressive bacteria introduced during the operation itself.^[3] Delayed onset infections develop between three and twelve months post-surgery (though some experts use twenty-four months as the cutoff) and typically involve less aggressive organisms that were also introduced during surgery but took longer to cause noticeable symptoms.^[3] Late onset infections, appearing more than a year or two after surgery, are most often the result of bacteria traveling through the bloodstream from other infection sites, though extremely slow-growing bacteria from the original surgery can also be responsible.^[3]

Recognizing the Signs of Infection

Detecting a prosthetic joint infection isn’t always straightforward because the classic signs of infection—high fever, severe swelling, and obvious illness—are often absent.^[1] Many patients experience subtler symptoms that can be mistaken for normal post-surgical recovery or other complications.

The most common symptom is persistent or increasing pain in a joint that had previously felt better.^[2] This pain may develop suddenly or gradually worsen over time. Other warning signs include warmth and redness around the joint, swelling that doesn’t improve, drainage from the surgical wound, and increasing stiffness when the joint had been improving.^[6] Some people experience general symptoms like fatigue, chills, night sweats, or fever, though these are not always present.^[6]

One particularly telling sign is a sinus tract—an abnormal channel that forms between the infected area and the skin surface, often draining pus or fluid.^[1] The presence of such a tract is considered strong evidence of infection requiring immediate medical attention.

Because symptoms can be vague or misleading, physicians rely on multiple diagnostic approaches to confirm infection. There is no single test that definitively proves or rules out infection in all cases.^[1] Instead, doctors use a combination of clinical examination, laboratory tests, imaging studies, and microbiological cultures to reach a diagnosis.

Blood tests can reveal elevated markers of inflammation, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), though these are not specific to infection and can be elevated for other reasons.^[3] More specific is the analysis of fluid drawn directly from the affected joint through a procedure called joint aspiration. This fluid is examined for white blood cells and cultured to identify any bacteria present—a positive culture is one of the strongest indicators of infection.^[1]

During surgery, tissue samples can be collected and analyzed both under a microscope and through culture. Multiple tissue samples are typically taken to increase the chance of identifying the causative organism and to distinguish true infection from contamination.^[3] International medical organizations have developed standardized criteria to help doctors determine when enough evidence exists to confidently diagnose a prosthetic joint infection, including definitions from the Musculoskeletal Infection Society and the International Consensus Meeting.^[3]

Standard Treatment Approaches

The treatment of medical device site joint infections is never simple. The presence of biofilm—that protective layer bacteria create on implant surfaces—makes these infections remarkably resistant to antibiotics alone.^[1] For this reason, successful treatment nearly always requires a combination of surgery and prolonged antibiotic therapy. The specific approach depends on multiple factors unique to each patient and their infection.

For infections detected very early—typically within a few weeks of the original surgery or within a few weeks of symptom onset—physicians sometimes attempt a procedure called debridement, antibiotics, and implant retention (DAIR).^[14] During this surgery, the surgeon thoroughly cleans the infected area, removes infected tissue, and often replaces modular plastic components while keeping the metal parts of the implant in place. This is followed by several weeks of intravenous antibiotics.^[13] This approach works best when the infection is caught quickly, the implant remains stable, and the bacteria involved are susceptible to antibiotics.^[14]

However, when infections are more established, when the implant has loosened, or when particularly resistant bacteria are involved, more extensive surgery becomes necessary. The most common approach is called two-stage revision or two-stage exchange. This involves two separate surgeries spaced several weeks or months apart.^[13] In the first stage, surgeons remove all implant components and surrounding infected tissue, then thoroughly clean the joint space. They typically place a temporary antibiotic-loaded spacer in the joint—a device impregnated with high doses of antibiotics that slowly releases medication directly into the infected area.^[13]

Between the two surgeries, patients receive intravenous antibiotics for at least six weeks, though the exact duration depends on the specific bacteria identified and how well the patient responds to treatment.^[13] An infectious disease specialist typically guides this antibiotic phase, adjusting medications based on culture results and monitoring for side effects.^[13] Blood tests are performed regularly to ensure infection markers are dropping to acceptable levels before proceeding with the second surgery.

During the second stage, once doctors are confident the infection has been cleared, the temporary spacer is removed and a new permanent prosthesis is implanted.^[13] This two-stage approach offers the highest success rates for eradicating infection, though it requires patients to endure an extended period with limited joint function and undergo two major surgeries.^[13]

A less common alternative is single-stage revision or one-stage exchange, where the infected implant is removed and a new one inserted during the same surgery.^[14] This approach may be considered in carefully selected patients with less aggressive infections and good overall health. While it offers the advantage of a single surgery and faster recovery, success rates are generally lower than with the two-stage approach.^[14]

For some patients—particularly those who cannot tolerate multiple surgeries due to poor health or those whose infections prove impossible to clear—permanent removal of the implant without replacement may be necessary. This procedure, called resection arthroplasty, leaves the patient without a functioning joint but resolves the infection.^[13] In extremely severe cases where infection has caused extensive tissue damage or threatens life, amputation may become the safest option, though this is rare.^[13]

Another option for select patients who cannot undergo surgery is long-term suppressive antibiotic therapy. This involves taking oral antibiotics indefinitely to keep the infection controlled rather than cured.^[14] While this doesn’t eliminate the infection, it can prevent symptoms and complications in patients too frail for surgery or those who decline further operations. However, this approach carries risks of antibiotic side effects, development of resistant bacteria, and the infection eventually breaking through despite medication.^[14]

Emerging Approaches Being Studied in Clinical Research

While standard treatments have improved over decades, medical device site joint infections remain challenging, prompting ongoing research into new strategies and therapies. Clinical trials are exploring various innovative approaches, though it’s important to understand that these are investigational and not yet proven to work better than current treatments.

One area of active research focuses on novel antimicrobial agents specifically designed to penetrate biofilms more effectively. Because biofilms represent the primary barrier to successful antibiotic treatment, researchers are testing new compounds with enhanced ability to break through this protective barrier and reach bacteria hiding within.^[13] Some studies examine combinations of existing antibiotics used in new ways, while others investigate entirely new classes of antimicrobial compounds.

Another promising research direction involves antibiotic-impregnated materials used during revision surgery. While antibiotic-loaded bone cement spacers are already standard practice, researchers are developing new materials that can deliver higher concentrations of antibiotics for longer periods, or that combine multiple antibiotics with different mechanisms of action.^[13] Some experimental implant coatings are being designed to release antibiotics slowly over many months or to have surfaces that resist bacterial attachment in the first place.

Several clinical trials are investigating whether immunotherapy approaches might help the body’s own defenses fight these infections more effectively. Since the implant itself weakens normal immune responses, researchers are studying whether boosting specific immune functions could improve infection clearance when combined with antibiotics and surgery.^[13] These approaches are still in early research phases.

Some studies are examining the potential role of bacteriophage therapy—using viruses that specifically target and kill bacteria. This approach is particularly interesting for infections caused by antibiotic-resistant organisms. While promising in laboratory settings, bacteriophage therapy for prosthetic joint infections is still primarily in experimental phases, with only small pilot studies reported.^[13]

Research is also ongoing into improved diagnostic technologies that could detect infections earlier or identify causative bacteria faster. Some clinical trials are testing molecular diagnostic methods that can identify bacterial DNA in joint fluid within hours rather than the days or weeks required for traditional cultures.^[3] Earlier, more accurate diagnosis could allow treatment to begin sooner, potentially improving outcomes.

Clinical trials examining these various approaches are conducted at specialized medical centers around the world, including institutions in the United States, Europe, and other regions. Patient eligibility for these trials typically depends on factors such as the type of infection, previous treatments attempted, overall health status, and specific characteristics of the bacteria involved. Patients interested in clinical trials should discuss options with their infectious disease specialist or orthopedic surgeon, who can determine whether any appropriate studies are available.^[3]

It’s essential to understand that participating in clinical research involves potential risks and benefits. While some patients may receive access to promising new therapies, others may receive standard treatment as part of comparison groups, and new treatments being tested may not work better than existing approaches—or could potentially have unexpected side effects. All clinical trials must be reviewed and approved by ethics committees to ensure patient safety is prioritized.^[3]

The Importance of Prevention

Given the complexity and difficulty of treating established infections, preventing them from occurring in the first place is critically important. Medical guidelines from organizations including the Infectious Diseases Society of America emphasize multiple strategies to reduce infection risk.^[7]

Before surgery, identifying and addressing modifiable risk factors can significantly reduce infection likelihood. Patients with uncontrolled diabetes are encouraged to optimize blood sugar levels before elective joint replacement.^[17] Weight loss for obese patients, smoking cessation programs, and treatment of malnutrition all contribute to better outcomes.^[17] Any active infections elsewhere in the body—from urinary tract infections to dental abscesses—should be treated before proceeding with joint replacement surgery.^[8]

During surgery, strict protocols help minimize bacterial contamination. These include administering prophylactic antibiotics before the incision is made, maintaining sterile technique throughout the procedure, using specialized air filtration systems in operating rooms, and completing surgery as efficiently as possible to minimize the time the joint is exposed.^[17] Surgical teams may also use antibiotic-impregnated cement when implanting components.^[17]

After surgery, patients are counseled to protect their implants from future infection. This includes taking prophylactic antibiotics before certain dental procedures that could introduce bacteria into the bloodstream, promptly treating any infections that develop elsewhere in the body, and maintaining good general health.^[2] Some guidelines recommend antibiotic prophylaxis before major dental work like tooth extractions or root canals for at least two years after joint replacement, though recommendations vary.^[8]

Most Common Treatment Methods

• Debridement with implant retention (DAIR)
  • Surgical cleaning of infected tissue while keeping the original implant in place
  • Replacement of removable plastic components
  • Most effective when performed within weeks of symptom onset or original surgery
  • Followed by several weeks of intravenous antibiotics
  • Success depends on implant stability and bacterial susceptibility
• Two-stage revision surgery
  • Complete removal of infected implant and tissue in first surgery
  • Placement of temporary antibiotic-loaded spacer
  • Extended period of intravenous antibiotic therapy (typically six weeks or longer)
  • Second surgery to implant new permanent prosthesis once infection cleared
  • Highest success rate for infection eradication
• One-stage revision surgery
  • Removal of infected implant and immediate replacement with new prosthesis in single operation
  • Considered for carefully selected patients with less aggressive infections
  • Requires thorough surgical debridement and cleaning
  • Followed by antibiotic therapy based on culture results
• Long-term suppressive antibiotics
  • Indefinite oral antibiotic therapy to control rather than cure infection
  • Reserved for patients who cannot tolerate surgery
  • Requires regular monitoring for side effects and treatment failure
  • Does not eliminate infection but prevents symptoms and complications
• Resection arthroplasty
  • Permanent removal of infected implant without replacement
  • Resolves infection but leaves patient without functioning joint
  • May allow limited mobility with assistive devices
  • Considered when revision surgery repeatedly fails or patient cannot tolerate further reconstruction
• Amputation
  • Surgical removal of affected limb in severe, life-threatening cases
  • Rare but necessary when infection causes extensive tissue destruction
  • Considered when infection cannot be controlled and threatens patient survival
  • Followed by rehabilitation and prosthetic limb fitting when appropriate